PFIZER THAILAND LIMITED

PFIZER THAILAND LIMITED

Company Type: Trading Company (Sales, Marketing, and Distribution Subsidiary)

Company Introduction:

PFIZER THAILAND LIMITED is the Thai subsidiary of Pfizer Inc., a leading global biopharmaceutical company committed to discovering, developing, and manufacturing innovative medicines and vaccines. In Thailand, PFIZER THAILAND LIMITED primarily operates as a commercial entity focused on the sales, marketing, and distribution of Pfizer's extensive portfolio of pharmaceutical products and vaccines. The company is responsible for importing these products into Thailand, promoting them to healthcare professionals, and ensuring their widespread availability to hospitals, clinics, and pharmacies throughout the country. Its mission is to bring global healthcare innovations to Thai patients, addressing various therapeutic areas including oncology, inflammation and immunology, rare diseases, internal medicine, and vaccines. While the company manages local operations, regulatory affairs, and may conduct clinical research, its core function in Thailand is the commercialization and distribution of Pfizer's global product line, rather than large-scale manufacturing.

PFIZER THAILAND LIMITED manufactures or sells a range of pharmaceutical products across various therapeutic areas. These include, but are not limited to, the following:

Vaccines

Comirnaty (COVID-19 Vaccine)

Prevenar 13 (Pneumococcal Conjugate Vaccine)

Oncology

Ibrance (Palbociclib)

Xtandi (Enzalutamide)

Bosulif (Bosutinib)

Xalkori (Crizotinib)

Inflammation and Immunology

Xeljanz (Tofacitinib)

Internal Medicine and Cardiovascular

Eliquis (Apixaban)

Vyndaqel (Tafamidis)

Anti-infectives and Hospital Products

Vfend (Voriconazole)

Zosyn (Piperacillin and Tazobactam)